{"anticipatedPostingDate":"2027-12","denomUnitsSelected":"Participants","description":"PFS2 was defined as the time from randomization to the date of progression of disease on first subsequent systemic anti-cancer therapy, or death from any cause, whichever occurred first","reportingStatus":"NOT_POSTED","timeFrame":"From time of Study Start up to 45 months","title":"PFS2 Based on Investigator's Assessment","type":"SECONDARY"}